⨯

working

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

LIBERUM: UK Small & Mid Cap Dispatches

Companies: FXPO MIND RENE

ReNeuron Group completes first dosing of patients in study for new degenerative eye disease therapy

Companies: ReNeuron Group plc

LIBERUM: ReNeuron* - Cuts ahead but path to upside intact

Companies: ReNeuron Group plc

ReNeuron (LON:RENE) Presenting at the Proactive One2One Virtual Forum 25th February 2021

Companies: ReNeuron Group plc

Cenkos: Duke Royalty Ltd -- A New Half and a New Path

Companies: Duke Royalty Limited

Copyright © 2022 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top